Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen, Justin D. Hoopes, Minh H. Le et al. · 2010
Read Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro by Jack T. Nguyen, Justin D. Hoopes, Minh H. Le et al. (2010) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/plos-pone-0009332.txt.
Description
Jack Nguyen and co-authors published this flu drug study in PLOS ONE in 2010. The 2009 H1N1 flu spread worldwide and was declared the first pandemic of the century. At the same time, flu strains were growing resistant to single drugs. A resistant virus can render a whole medicine cabinet useless.
The team tested three flu drugs together: amantadine, ribavirin, and oseltamivir. In lab dishes, the triple mix was highly active against drug-resistant strains. The drugs also boosted each other, an effect called synergy. Combining drugs makes resistance harder, because the virus must escape all three at once.
Catalog record
| CREATOR | Jack T. Nguyen, Justin D. Hoopes, Minh H. Le et al. |
|---|---|
| YEAR | 2010 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 65 KB |
| LICENSE | Creative Commons CC0 License |
| RIGHTS | CC0 |
| SOURCE | PLOS ONE |
Source: https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0009332